Search results
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 7 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock. | The Motley...
The Motley Fool· 4 days agoGenerating dividend income can be an excellent way to put your cash to work. Pfizer pays a quarterly...
When Donald Trump was asked about Taylor Swift, he commented on her appearance
Philly.com· 2 days agoDonald Trump has thoughts on Taylor Swift — but they’re not about her sold-out international tour or...
New COVID Vaccines Targeting JN.1 Will Arrive This Fall
Verywell Health via Yahoo News· 5 days agoVaccine manufacturers, including Pfizer, Moderna, and Novavax, have already been working on a JN.1...
Relay in clinical trial collaboration with Pfizer for breast cancer combo treatment
Seeking Alpha· 7 days agoRelay Therapeutics collaborates with Pfizer to investigate combination therapy for breast cancer using RLY-2608 and atirmociclib. Read more here.
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
AOL· 5 days agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according a study by Stanford University researchers. Currently, ...
Bioscience jobs growth recently stalled in CT. But industry supporters are still optimistic.
Stamford Advocate· 3 hours agoJobs growth in Connecticut's bioscience industry stalled last year, according to new state data —...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 5 days agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
Colorado Springs Gazette· 5 days agoCurrently, there are no proven treatments specifically for long COVID in which a host of symptoms can last for many months after initial coronavirus infection. Scientists and patients had hoped ...
Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment
Morningstar· 7 days agoRelay Therapeutics will collaborate with Pfizer to study atirmociclib in combination with RLY-2608 and fulvestrant in patients with certain types of metastatic breast cancer ...